Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro

Molecular Psychiatry

Volumn 3, Issue 3, 1998, Pages 247-255

  Calderon F H ^a   Von Bernhardi, R ^a   De Ferrari, G ^a   Luza, S ^a   Aldunate, R ^a   Inestrosa, N C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Neurotoxicity; Non cholinergic action; Senile plaques

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMYLOID; AMYLOID BETA PROTEIN; NEUROTRANSMITTER;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL DENSITY; CELL SIZE; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DEGENERATIVE DISEASE; DNA STRAND BREAKAGE; DRUG HYDROLYSIS; GLIA CELL; MOUSE; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SENILE PLAQUE;

EID: 0031782138     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000383     Document Type: Article

References (52)

1. Bondi MW, Salmon DP, Butters NM. Neuropsychological features of memory disorders in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds). Alzheimer Disease. Raven Press: New York, 1994, pp 41-63.
2. Hyman BT, Van Hoosen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984; 225: 1168-1170.
3. Selkoe DJ. Amyloid β-protein and the genetics of Alzheimer's disease. J Biol Chem 1996; 271: 18295-18298.
4. Whitehouse PJ, Price DL, Struble RG, Coyle JT, DeLong MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215: 1237-1239.
5. Sandbrink R, Beyreuther K. Unraveling the molecular pathway of Alzheimer's disease: research about presenilins gathers momentum. Mol Psychiatry 1996; 1: 438-444.
6. Selkoe DJ. Alzheimer's disease: genotypes, phenotype, and treatments. Science 1997; 275: 630-631.
7. Haass C. Presenilins: genes for life and death. Neuron 1997; 18: 687-690.
8. Yankner BA. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996; 16: 921-932.
9. Soto C, Brañes MC, Alvarez J, Inostrosa NC. Structural determinants of the Alzheimer's amyloid β-peptide. J Neurochem 1994; 63: 1191-1198.
10. Iversen LL, Mortishire-Smith J, Pollack SJ, Shearman MS. The toxicity in vitro of β-amyloid protein. Biochem J 1995; 311: 1-16.
11. Greenfield S. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem Int 1996; 28: 485-490.
12. Inestrosa NC, Alvarez A, Pérez C, Moreno D, Vicente M, Linker C et al. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 1996; 16: 1-20.
13. Inestrosa NC, Alvarez A, Calderón FH. Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid β-peptide into Alzheimer's filaments. Mol Psychiatry 1996; 1: 359-361.
14. Inestrosa NC, Alvarez A, Garrido J, Calderón FH, Bronfman FC, Dajas F et al. Acetylcholinesterase promotes Alzheimer β-amyloid fibril formation. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniowski HM (eds). Alzheimer's Disease: Biology, Diagnosis and Therapeutics. John Wiley & Sons: London, 1997.
15. 4) acetylcholinesterase: structure, localization, and physiological regulation. J Neurochem 1996; 66: 1335-1346.
16. Inestrosa NC, Perelman A. Distribution and anchoring of molecular forms of acetylcholinesterase. Trends Pharmacol Sci 1989; 10: 325-329.
17. Massoulié J, Pezzementi L, Bon S, Krejci E, Vallette FM. Molecular and cellular biology of cholinesterases. Prog Neurobiol 1993; 41: 31-91.
18. Geula C, Mesulam MM. Cholinorgic systems and related neuropathological predilection patterns in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds). Alzheimer Disease. Raven Press: New York, 1994, pp 263-269.
19. Struble RG, Cork LC, Whitehouse PJ, Price DL. Cholinergic innervation in neuritic plaques. Science 1982; 216: 413-415.
20. Beeri R, Andres C, Lev-Lehman E, Timberg R, Huberman T, Shani M et al. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol 1995; 5: 1063-1071.
21. Atack JR, Perry EK, Bonham JR, Perry RH, Tomlinson BE, Blessed G et al. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer's type: selective loss of the intermediate (10S) form. Neurosci Lett 1983; 40: 199-204.
22. Fishman EB, Siek GC, MacCallum RD, Bird ED, Volicer L, Marquis JK. Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann Neurol 1986; 19: 246-252.
23. Younkin SG, Goodridge B, Katz J, Lockett G, Nafziger D, Usiak MF et al. Molecular forms of acetylcholinesterase in Alzheimer's disease. Fed Proc 1986; 45: 2982-2988.
24. Arendt T, Brückner MK, Lange M, Bigl V. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development. A study of molecular forms. Neurochem Int 1992; 21: 381-396.
25. Gómez-Ramos P, Mufson EJ, Morán MA. Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil and senile plaques in aged and Alzheimer's brain. Brain Res 1992; 569: 229-237.
26. Kalaria RN, Kroon SN, Grahovac I, Perry G. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease. Neuroscience 1992; 51: 177-184.
27. Morán MA, Mufson EJ. Gómez-Ramos P. Colocalization of cholinesterases with β-amyloid protein in aged and Alzheimer's brain. Acta Neuropathol 1993; 85: 362-369.
28. Small DH, Michaelson S, Sberna G. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem Int 1996; 28: 453-483.
29. Shen ZX. Acetylcholinesterase provides deeper insights into Alzheimer's disease. Med Hypoth 1994; 43: 21-30.
30. Smith AD, Cuello AC. Alzheimer's disease and acetylcholinesterase-containing neurons. Lancet 1984; I: 513.
31. Calderón FH, De Ferrari GV, Luza SC, von Bernhardi R, Inestrosa NC. Toxic effects of acetylcholinesterase in neuronal cell cultures. Molec Biol Cell (Suppl) 1996; 7: 652a, 3791.
32. Bronfman FC, Fernández HL, Inestrosa NC. Amyloid precursor protein fragment and acetylcholinesterase increase with cell confluence and differentiation in a neuronal cell line. Exp Cell Res 1996; 229: 93-99.
33. Prasad KN. Differentiation of neuroblastoma cells in culture. Biol Rev 1975; 50: 129-265.
34. Schubert D, Heinemann S, Carlisle W, Tarikas H, Kimes B, Steinbach JH et al. Clonal cell lines from the rat central nervous system. Nature 1974; 249: 224-227.
35. Inestrosa NC, Roberts WL, Marshall T, Rosenberry TL. Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterase in other tissues. J Biol Chem 1987; 262: 4441-4444.
36. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
37. Inestrosa NC, Silberstein L, Hall ZW. Association of the synaptic form of acetylcholinesterase with extracellular matrix in cultured mouse muscle cells. Cell 1982; 29: 71-79.
38. Koh JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Meth 1987; 20: 83-90.
39. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Meth 1983; 65: 55-63.
40. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of DNA fragmentation. J Cell Biol 1992; 119: 493-501.
41. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 1994; 10: 41-42.
42. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
43. Sussman JL, Silman I. Acetylcholinesterase: structure and use as a model for specific cation-protein interactions. Curr Opin Struct Biol 1992; 2: 721-729.
44. Eichler J, Anselmet A, Sussman JL, Massoulie J, Silman I. Differential effects of 'peripheral' site ligands on Torpedo and chicken acetylcholinesterase. Mol Pharmacol 1994; 45: 335-340.
45. Layer PG, Weikert T, Alber R. Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Cell Tissue Res 1993; 273: 219-226.
46. Dickie BGM, Budd TC, Vaux D, Greenfield SA. Uptake of acetylcholinesterase by neurons in the substantia nigra. Eur J Neurosci 1995; 7: 351-357.
47. Klegeris A, Budd TC, Greenfield SA. Acetylcholinesterase activation of peritoneal macrophages is independent of catalytic activity. Cell Molec Neurobiol 1994; 14: 89-98.
48. Klegoris A, Budd TC, Greenfield SA. Acetylcholinesterase-induced respiratory burst in macrophages: evidence for the involvement of the macrophage mannose-fucose receptor. Biochem Biophys Acta 1996; 1289: 159-168.
49. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinsky M, Jellinger K et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995; 89: 35-41.
50. Su JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 1994; 5: 2529-2533.
51. Terry RD, Masliah E, Hansen LA. Structural basis of the cognitive alterations in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds). Alzheimer Disease. Raven Press: New York, 1994, pp 179-196.
52. Korotzer AR, Pike CJ, Cotman CW. Beta-amyloid peptides induce degeneration of cultured rat microglia. Brain Res 1993; 624: 121-125.